An Easy Read document for people with intellectual disability. It aims to support people with intellectual disability, their supporters and clinicians to talk about the person’s disability and what they need to make their health care accessible.

The standard contains eight quality statements that describe the health care you should receive to support the correct use of psychotropic medicines. This fact sheet explains each quality statement and what it means for you.  

On 21 March 2022, the Australian Commission on Safety and Quality in Health Care, the Aged Care Quality and Safety Commission and the NDIS Quality and Safeguards Commission have launched the Joint Statement on the important issue of inappropriate use of psychotropic medicines with people with disability and older people as a form of restrictive...

The Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard contains eight quality statements and seven indicators to ensure the safe and appropriate use of psychotropic medicines in people with cognitive disability or impairment and uphold their rights, dignity, health and quality of life.

This resource lists the eight quality statements in the clinical care standard that aim to ensure the safe and appropriate use of psychotropic medicines in people with cognitive disability or impairment.

This resource accompanies the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard. It describes what the quality statements mean for healthcare services and provides indicators to support local quality improvement activity.